Replies to post #154205 on Biotech Values

[ariadndndough]

at the ASH 2011 presentation briefing around slide 20 it talks about the the deaths and how sick the patients were. i am having troulbe copying it but you can take look here.

there was no concerns about Ponatinib or emerging trends then.


http://phx.corporate-ir.net/phoenix.zhtml?c=118422&p=InvestorDownloads